Market Place
Sourcing Support
US FDA approves Novo Nordisk`s bleeding disorder drug
21 Dec 2024 //
REUTERS
Novo stock crashes after CagriSema misses weight-loss goal
21 Dec 2024 //
FIERCE BIOTECH
Novo Adds Novel Approach to Cardiometabolic With Photys Collab
19 Dec 2024 //
GLOBENEWSWIRE
Obesity giants will begin $80 bln M&A face-off
19 Dec 2024 //
REUTERS
Novo Holdings Completes Acquisition of Catalent
18 Dec 2024 //
BUSINESSWIRE
Novo Nordisk`s Ozempic faces EU review for potential eye disease connection
18 Dec 2024 //
REUTERS
Nestle launches protein shots for US weight-loss drug
18 Dec 2024 //
REUTERS
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Novo`s Ozempic faces scrutiny over potential link to rare eye disease
17 Dec 2024 //
REUTERS
Novo invests $1.2 bln in new rare disease drugs plant in Denmark
17 Dec 2024 //
REUTERS
Regulatory conditions on Novo $16.5 billion Catalent deal fulfilled
16 Dec 2024 //
PRESS RELEASE
Novo holding Clears Catalent Buy & 3 Novo Nordisk Sites Acquisitions
14 Dec 2024 //
PRESS RELEASE
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
14 Dec 2024 //
BIOSPACE
Lilly`s Mounjaro Beats Wegovy In UK Obesity Drug Market
12 Dec 2024 //
REUTERS
Evotec, Novo Nordisk Launch LAB eN(2) Drug Discovery Projects
11 Dec 2024 //
ACCESSWIRE
Eikonizo Therapeutics Announces Investment by Novo for EKZ-102
10 Dec 2024 //
BUSINESSWIRE
Novo Holdings` $16.5 bln Catalent buy wins EU antitrust approval
09 Dec 2024 //
PRESS RELEASE
HIBISCUS Phase 2 Data Shows Promise In Sickle Cell Disease
07 Dec 2024 //
PR NEWSWIRE
Novo Nordisk to slash prices of Fiasp, Tresiba in 2026
06 Dec 2024 //
FIERCE PHARMA
Novo`s to cut US list price of 2 insulin products by more than70%
06 Dec 2024 //
PRFESS RELEASE
FDA chief Defends Obesity Work Before Senate RFK Jr Criticism
06 Dec 2024 //
REUTERS
Lilly`s Zepbound Beats Wegovy In Weight Loss Trial: 20.2% Vs. 13.7%
05 Dec 2024 //
PR NEWSWIRE
Novo unveils plans for $400M quality control hub in Denmark
05 Dec 2024 //
FIERCE PHARMA
Novavax sells Czech production plant to Novo Nordisk for $200M
04 Dec 2024 //
FIERCE PHARMA
Novo Presents Data from Sickle Cell & Hemophilia Trials at ASH
03 Dec 2024 //
GLOBENEWSWIRE
Novo Nordisk Highlights Rare Blood Disorders at ASH 2024
03 Dec 2024 //
PR NEWSWIRE
Novo India execs urge early Wegovy launch as weight-loss rival
03 Dec 2024 //
ECONOMICTIMES
Novo Nordisk A/S - share repurchase programme
25 Nov 2024 //
GLOBENEWSWIRE
Thousands turn to Wegovy copies each month as FDA consider shortage
25 Nov 2024 //
REUTERS
Novo Holdings set to win EU nod for $16.5 bln Catalent deal
23 Nov 2024 //
REUTERS
Ypsomed will make injection pens for Novo Nordisk`s CagriSema
22 Nov 2024 //
REUTERS
Novo Nordisk A/S: Trading In Shares By Board Members & Executives
19 Nov 2024 //
GLOBENEWSWIRE
Essence Ph 3 Shows Semaglutide 2.4 mg Benefits for MASH at AASLD
19 Nov 2024 //
PR NEWSWIRE
Novo Nordisk launches obesity drug Wegovy in China
19 Nov 2024 //
REUTERS
Novo Nordisk A/S - share repurchase programme
18 Nov 2024 //
GLOBENEWSWIRE
Novo to gradually phase out production of human insulin pens
16 Nov 2024 //
FIERCE PHARMA
Omega halts sole clinical-stage asset to focus on 3 programs
15 Nov 2024 //
FIERCE BIOTECH
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
13 Nov 2024 //
REUTERS
Novo Nordisk A/S: Trading by Board, Execs & Associates
13 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk Shares Trading by Executives & Board Members
12 Nov 2024 //
GLOBENEWSWIRE
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
12 Nov 2024 //
FIERCE PHARMA
US Minority Veterans Face Unequal Access to Ozempic, Wegovy
11 Nov 2024 //
REUTERS
Novo Nordisk Share Trading by Board Members, Execs & More
08 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk Purchases DKK 4.7B B Shares in Repurchase
08 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk A/S - share repurchase programme
08 Nov 2024 //
GLOBENEWSWIRE
Novo Share Trading by Board Members, Execs & Associated Person
08 Nov 2024 //
GLOBENEWSWIRE
Novo Nordisk Reports Share Trading by Board & Executives
07 Nov 2024 //
GLOBENEWSWIRE
Novo discards $1.3B kidney drug in wake of phase 3 fail
07 Nov 2024 //
FIERCE BIOTECH
Novo expects high demand for its obesity drugs in India
07 Nov 2024 //
REUTERS
Novo Nordisk Reports 23% Sales Growth in First 9 Months of 2024
06 Nov 2024 //
GLOBENEWSWIRE
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
06 Nov 2024 //
FIERCE PHARMA
Novo affirms 25% weight-loss for experimental drug CagriSema
06 Nov 2024 //
REUTERS
Novo CFO says 2025 sales could see high-teens percentage growth
06 Nov 2024 //
REUTERS
Novo`s Wegovy weight-loss drug sales beat forecast, shares jump
06 Nov 2024 //
REUTERS
Novo is aware of 10 deaths from compounded weight-loss drug copies
06 Nov 2024 //
REUTERS
Novo Nordisk A/S - share repurchase programme
05 Nov 2024 //
GLOBENEWSWIRE
Catalent Misses Q1 Revenue Estimates Before Novo Holdings Deal
05 Nov 2024 //
REUTERS
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
05 Nov 2024 //
BIOSPACE
AstraZeneca says experimental obesity pill safe in early-stage trial
05 Nov 2024 //
REUTERS
Novo`s trial of weight-loss drug improvement in fatty liver disease
04 Nov 2024 //
REUTERS
